Reshma Kewalramani - Net Worth and Insider Trading
Reshma Kewalramani Net Worth
The estimated net worth of Reshma Kewalramani is at least $43 Million dollars as of 2024-04-27. Reshma Kewalramani is the CEO & President of Vertex Pharmaceuticals Inc and owns about 108,711 shares of Vertex Pharmaceuticals Inc (VRTX) stock worth over $43 Million. Details can be seen in Reshma Kewalramani's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Reshma Kewalramani has not made any transactions after 2023-12-15 and currently still holds the listed stock(s).
Transaction Summary of Reshma Kewalramani
Reshma Kewalramani Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Reshma Kewalramani owns 2 companies in total, including Vertex Pharmaceuticals Inc (VRTX) , and Ginkgo Bioworks Holdings Inc (DNA) .
Click here to see the complete history of Reshma Kewalramani’s form 4 insider trades.
Insider Ownership Summary of Reshma Kewalramani
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| VRTX | Vertex Pharmaceuticals Inc | 2023-12-15 | director & CEO & President |
| DNA | Ginkgo Bioworks Holdings Inc | 2021-09-16 | director |
Reshma Kewalramani Latest Holdings Summary
Reshma Kewalramani currently owns a total of 1 stock. Reshma Kewalramani owns 108,711 shares of Vertex Pharmaceuticals Inc (VRTX) as of December 15, 2023, with a value of $43 Million.
Latest Holdings of Reshma Kewalramani
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| VRTX | Vertex Pharmaceuticals Inc | 2023-12-15 | 108,711 | 397.48 | 43,210,448 |
Holding Weightings of Reshma Kewalramani
Reshma Kewalramani Form 4 Trading Tracker
According to the SEC Form 4 filings, Reshma Kewalramani has made a total of 20 transactions in Vertex Pharmaceuticals Inc (VRTX) over the past 5 years, including 1 buys and 19 sells. The most-recent trade in Vertex Pharmaceuticals Inc is the sale of 17,135 shares on December 15, 2023, which brought Reshma Kewalramani around $7 Million.
Insider Trading History of Reshma Kewalramani
- 1
Reshma Kewalramani Trading Performance
GuruFocus tracks the stock performance after each of Reshma Kewalramani's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Reshma Kewalramani is -6.23%. GuruFocus also compares Reshma Kewalramani's trading performance to market benchmark return within the same time period. The performance of stocks bought by Reshma Kewalramani within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Reshma Kewalramani's insider trading performs compared to the benchmark.
Performance of Reshma Kewalramani
Average Return
53.32%
Outperforming Transactions
100%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -3.46 | -6.23 | 17.72 | 53.32 | 33.02 | |
| Relative Return to S&P 500(%) | -4.08 | -12.86 | 19.01 | 57.34 | 33.43 |
Reshma Kewalramani Ownership Network
Ownership Network List of Reshma Kewalramani
Ownership Network Relation of Reshma Kewalramani
Reshma Kewalramani Owned Company Details
What does Vertex Pharmaceuticals Inc do?
Who are the key executives at Vertex Pharmaceuticals Inc?
Reshma Kewalramani is the director & CEO & President of Vertex Pharmaceuticals Inc. Other key executives at Vertex Pharmaceuticals Inc include SVP & Chief Accounting Officer Kristen Ambrose , EVP & Chief Technical Ops. Off. Atkinson Edward Morrow Iii , and EVP & Global Research and CSO David Altshuler .
Vertex Pharmaceuticals Inc (VRTX) Insider Trades Summary
Over the past 18 months, Reshma Kewalramani made 5 insider transaction in Vertex Pharmaceuticals Inc (VRTX) with a net sale of 43,378. Other recent insider transactions involving Vertex Pharmaceuticals Inc (VRTX) include a net sale of 32,309 shares made by David Altshuler , a net sale of 53,744 shares made by Stuart A Arbuckle , and a net sale of 11,187 shares made by Ourania Tatsis .
In summary, during the past 3 months, insiders sold 66,939 shares of Vertex Pharmaceuticals Inc (VRTX) in total and bought 0 shares, with a net sale of 66,939 shares. During the past 18 months, 380,077 shares of Vertex Pharmaceuticals Inc (VRTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 380,077 shares.
Vertex Pharmaceuticals Inc (VRTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Vertex Pharmaceuticals Inc Insider Transactions
Reshma Kewalramani Mailing Address
Above is the net worth, insider trading, and ownership report for Reshma Kewalramani. You might contact Reshma Kewalramani via mailing address: C/o Vertex Pharmaceuticals, Inc., 50 Northern Avenue, Boston Ma 02210.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
